Identification, characterization and targeting of Docetaxel-resistant prostate cancer cells.

about

Identification, characterization and targeting of Docetaxel-resistant prostate cancer cells.

Item

http://www.wikidata.org/entity/Q42140492

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Identification, characterizati ...... sistant prostate cancer cells.

@en

Identification, characterizati ...... sistant prostate cancer cells.

@nl

type

Item

label

Identification, characterizati ...... sistant prostate cancer cells.

@en

Identification, characterizati ...... sistant prostate cancer cells.

@nl

prefLabel

Identification, characterizati ...... sistant prostate cancer cells.

@en

Identification, characterizati ...... sistant prostate cancer cells.

@nl

P1476

Identification, characterizati ...... sistant prostate cancer cells.

@en

P2093

Tanya I Stoyanova

http://www.w3.org/2001/XMLSchema#string

P2860

The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.

Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.

Castration-resistant prostate cancer: mechanisms, targets, and treatment.

Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax.

Overcoming castration resistance in prostate cancer.

P304

83-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJA.2012.133

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew S Goldstein

P577

2012-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23202701

http://www.w3.org/2001/XMLSchema#string

P932

3739119

http://www.w3.org/2001/XMLSchema#string